Home > Insider Trading > Filing (0001209191-21-012347)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Adm, Leg & Bd Off	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-17	6,240	$211.75	44,106	No	4	F	Direct
Common Stock	Disposition	2021-02-18	1,007	$210.08	43,099	No	4	S	Direct
Common Stock	Disposition	2021-02-18	4,666	$211.83	38,433	No	4	S	Direct
Common Stock	Disposition	2021-02-18	1,952	$212.56	36,481	No	4	S	Direct
Common Stock	Disposition	2021-02-18	200	$213.45	36,281	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $210.08 (range $209.60 to $210.54).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $211.83 (range $211.25 to $212.24).
Open market sales reported on this line occurred at a weighted average price of $212.56 (range $212.25 to $212.95).
Open market sales reported on this line occurred at a weighted average price of $213.45 (range $213.30 to $213.68).